Obagi Medical Products’ Reports Second Quarter 2012 EPS Rose to $0.18 vs. $0.16 a Year Ago; Revenue Rose to $30.5 million
16:05 EDT 2 Aug 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Obagi Medical Products, Inc. (NASDAQ: OMPI), a leader in topical
aesthetic and therapeutic skin health systems, today reported financial
results for the second quarter and six months ended June 30, 2012.
Net sales for t...
Other Sources for this Article
Obagi Medical Products, Inc.
Preston Romm
CFO, EVP of Finance,
Operations & Administration
562.628.1007
or
McGuinness
Consulting
Ina McGuinness
805.427.1372
More From BioPortfolio on "Obagi Medical Products’ Reports Second Quarter 2012 EPS Rose to $0.18 vs. $0.16 a Year Ago; Revenue Rose to $30.5 million"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
